<code id='CF5BB188A3'></code><style id='CF5BB188A3'></style>
    • <acronym id='CF5BB188A3'></acronym>
      <center id='CF5BB188A3'><center id='CF5BB188A3'><tfoot id='CF5BB188A3'></tfoot></center><abbr id='CF5BB188A3'><dir id='CF5BB188A3'><tfoot id='CF5BB188A3'></tfoot><noframes id='CF5BB188A3'>

    • <optgroup id='CF5BB188A3'><strike id='CF5BB188A3'><sup id='CF5BB188A3'></sup></strike><code id='CF5BB188A3'></code></optgroup>
        1. <b id='CF5BB188A3'><label id='CF5BB188A3'><select id='CF5BB188A3'><dt id='CF5BB188A3'><span id='CF5BB188A3'></span></dt></select></label></b><u id='CF5BB188A3'></u>
          <i id='CF5BB188A3'><strike id='CF5BB188A3'><tt id='CF5BB188A3'><pre id='CF5BB188A3'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:17
          Darron Cummings/AP

          Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

          The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

          advertisement

          Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          The haunting brain science of long Covid
          The haunting brain science of long Covid

          AdobeMattFitzgeraldusedtobikeupanddown3,500feetthroughtheSantaAnaMountainsonthree-hourridesjustforfu

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          'Investigate these claims': UFO transparency at center of House hearing

          3:47RyanGraves,DavidGrusch,andDavidFravorattendtheHouseOversight&AccountabilityCommittee'sNationalSe